4

PRIMARY DOCUMENT

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed: December 9, 2020
Period of Report: December 3, 2020
Accession Number: 0001076809-20-000307

View Document ↗ View on SEC.gov ↗